-+ 0.00%
-+ 0.00%
-+ 0.00%

TYRA BIOSCIENCES SHARES FALL 35.7% PREMARKET; CO ANNOUNCES INITIAL PHASE 2 SURF302 RESULTS FOR ORAL DABOGRATINIB

Reuters·09/09/2026 11:05:23

Please log in to view news